Molecular Testing in Metastatic Gastric/GEJ Cancer
3 Vues
• 06/30/23
0
0
Intégrer
administrator
Les abonnés
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires